BiomX Inc. (PHGE)
AMEX: PHGE
· Real-Time Price · USD
0.55
0.05 (9.32%)
At close: Aug 15, 2025, 3:59 PM
0.55
-0.33%
After-hours: Aug 15, 2025, 07:54 PM EDT
BiomX Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 172K | -84K | n/a | -88K | -87K | -89K | -90K | -91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | -2.58M | 322K | 331K | 229K | 212K | 219K | 217K | 223K | 624K | 629K | 635K | 632K | 819K | 625K | 566K | 555K |
Gross Profit | n/a | 2.75M | -84K | -331K | -317K | -299K | -219K | -307K | -314K | -624K | -629K | -635K | -632K | -819K | -625K | -566K | -555K |
Operating Income | -7.76M | -9.4M | -10.61M | -9.72M | -6.79M | -5.27M | -382K | -6.07M | -6.21M | -5.56M | -6.55M | -7.32M | -7.79M | -61.14M | -9.83M | -7.3M | -8.67M |
Interest Income | n/a | 1.1M | 332K | 329K | n/a | 215K | 382K | 325K | 327K | n/a | 280K | 339K | 87K | 77K | n/a | n/a | 143K |
Pretax Income | -7.66M | -14.51M | 9.64M | 4.48M | -17.32M | -5.49M | -7.9M | -6.4M | -6.36M | -5.85M | -6.77M | -7.47M | -8.16M | -10.41M | -10.02M | -7.33M | -8.4M |
Net Income | -7.66M | -14.51M | -9.64M | 4.47M | -17.33M | -5.49M | -382K | -6.41M | -6.36M | -5.89M | -6.78M | -7.48M | -8.17M | -10.46M | -10.01M | -7.34M | -8.4M |
Selling & General & Admin | 2.51M | 2.13M | 3.25M | 2.83M | 2.45M | 2.38M | 2.15M | 2.25M | 1.64M | 1.99M | 2.63M | 2.36M | 2.48M | 2.83M | 2.85M | 2.91M | 2.5M |
Research & Development | 5.25M | 6.38M | 7.28M | 6.9M | 4.11M | 2.67M | 5.64M | 3.82M | 4.56M | 3.19M | 3.54M | 4.58M | 4.93M | 6.57M | 6.61M | 3.82M | 5.79M |
Other Expenses | n/a | 8.17M | 801K | n/a | n/a | n/a | 89K | 90K | 91K | 380K | 380K | 379K | 380K | 380K | 380K | 380K | 379K |
Operating Expenses | 7.76M | 9.96M | 11.33M | 9.72M | 6.56M | 5.06M | 7.79M | 6.07M | 6.21M | 5.56M | 6.55M | 7.32M | 7.79M | 9.79M | 9.83M | 7.3M | 8.12M |
Interest Expense | 5K | 5K | 5K | 13K | 850K | 520K | 574K | 745K | 565K | 565K | 555K | 488K | 461K | 621K | 188K | 31K | n/a |
Selling & Marketing Expenses | n/a | 560K | n/a | n/a | -229K | -212K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.76M | 7.38M | 11.33M | 9.72M | 6.79M | 5.27M | 7.79M | 6.07M | 6.21M | 5.56M | 6.55M | 7.32M | 7.79M | 9.79M | 9.83M | 7.3M | 8.67M |
Income Tax Expense | 1K | 3K | n/a | 5K | 5K | 1K | 8K | 8K | 6K | 39K | 8K | 9K | 9K | 51K | 10K | 3K | 3K |
Shares Outstanding (Basic) | 23.1M | 69.81M | 69.81M | 69.81M | 62.29M | 45.98M | 60.59M | 51.55M | 32.13M | 29.98M | 29.91M | 29.77M | 29.75M | 28.49M | 27.08M | 24.32M | 23.94M |
Shares Outstanding (Diluted) | 23.1B | 181.77M | 163.88M | 107.5M | 62.29M | 45.98M | 60.59M | 51.55M | 32.13M | 29.98M | 29.91M | 29.77M | 29.75M | 28.49M | 27.08M | 24.32M | 23.94M |
EPS (Basic) | -3.3 | -0.21 | -0.14 | 0.10 | -27.8 | -1.19 | -1.3 | -1.2 | -2 | -1.96 | -2.3 | -2.5 | -2.7 | -3.67 | -3.7 | -3 | -3.51 |
EPS (Diluted) | -3.3 | -2.25 | 0.31 | -0.7 | -27.8 | -1.19 | -1.3 | -1.2 | -2 | -1.96 | -2.3 | -2.5 | -2.7 | -3.67 | -3.7 | -3 | -3.51 |
EBITDA | -7.42M | -14.69M | 9.97M | 4.82M | -16.24M | -4.76M | -7.11M | -5.44M | -5.57M | -4.66M | -5.59M | -6.35M | -7.07M | -8.96M | -9.22M | -6.77M | -7.84M |
EBIT | -6.85M | -14.51M | 9.65M | 4.49M | -16.47M | -4.97M | -7.32M | -5.66M | -5.79M | -5.28M | -6.22M | -6.99M | -7.7M | -9.78M | -9.85M | -7.33M | -8.4M |
Depreciation & Amortization | 236K | 921K | 322K | 331K | 229K | 212K | 219K | 217K | 223K | 624K | 629K | 635K | 632K | 819K | 625K | 566K | 555K |